Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
9 trials
Recent
Start date
Enrollment
Phase 3
×
Recruiting
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Clear all
Filters
3
NCT06345729
2026-03-16
KANDLELIT-004
Merck Sharp & Dohme LLC
Phase 3
Recruiting
600 enrolled
NCT06170788
2026-03-13
TroFuse-007
Merck Sharp & Dohme LLC
Phase 3
Recruiting
614 enrolled
NCT06312176
2026-03-13
MK-2870-010
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,200 enrolled
NCT06841354
2026-03-13
TroFuse-011
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,000 enrolled
NCT06952504
2026-03-13
TroFuse-033
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,123 enrolled
NCT07216703
2026-03-13
TroFuse-036
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,023 enrolled
NCT06989112
2026-03-12
DE-01
AstraZeneca
Phase 3
Recruiting
600 enrolled
NCT06623422
2026-03-11
INTerpath-009
Merck Sharp & Dohme LLC
Phase 3
Recruiting
680 enrolled
NCT05239741
2026-03-10
MK-3475-C66
Merck Sharp & Dohme LLC
Phase 3
Recruiting
100 enrolled